SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-038366
Filing Date
2020-06-23
Accepted
2020-06-23 07:14:45
Documents
1
Period of Report
2020-06-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4839
  Complete submission text file 0001209191-20-038366.txt   6414
Mailing Address 1001 MAIN STREET SUITE 600 BUFFALO NY 14203
Business Address 1001 MAIN STREET SUITE 600 BUFFALO NY 14203 716-898-8625
Athenex, Inc. (Issuer) CIK: 0001300699 (see all company filings)

IRS No.: 431985966 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O ATHENEX, INC., 1001 MAIN STREET SUITE 600 BUFFALO NY 14203
Business Address
Bair Teresa Brophy (Reporting) CIK: 0001813058 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38112 | Film No.: 20980276